Normal Balloon Catheter Market

Introduction

Normal balloon catheter, an innovative medical device, comprises a catheter and a guidewire that is inserted into the femoral artery in the legs, or, sometimes into the radial artery in arms for treating constricted blood vessels. Generally, normal balloon catheter is utilized for preventing blood vessel constriction, which is caused by atherosclerosis, i.e. deposition of the lipid substances in blood vessels.

The surge in interventional cardiology has been facilitating the utilization of normal balloon catheters. Moreover, there is a rise in the prevalence of patients affected with end-stage renal disease. The number of patients seeking renal replacement therapy has also increased. Leading manufacturers of normal balloon catheters are developing efficient and cost-effective solutions.

These incidences might influence growth of the global normal balloon catheter market in the upcoming years. In contrast, costs of angioplasty procedures are very high, coupled with the risks such as artery collapse and infection related to balloon catheterization, which in turn will impede the growth of the market.

The number of cardiovascular diseases has been witnessing a rise, along with growing cases of cardiology intervention procedures worldwide. Several governments are providing reimbursement support for people suffering from vascular diseases. There has also been a hike in healthcare expenditure. These factors might favor demand for normal balloon catheters.

In addition, various other factors such as the growing geriatric population, rising investments in research & development activities concerning normal balloon catheters are expected to pave potential growth opportunities for manufacturers of normal balloon catheters.

The global normal balloon catheter market is likely to exhibit moderate growth from 2017 to 2022. Revenues from the global market for normal balloon catheter will reach nearly US$ 2,000 Mn by 2022-end.

Europe to Account for the Largest Revenue Share of the Market during 2017 to 2022

In terms of revenues, Europe will account for the largest share of the market during the forecast period. Europe will continue to be the most lucrative market for the normal balloon catheter. Sales of normal balloon catheter in Asia-Pacific excluding Japan (APEJ) will register the highest CAGR through 2022. In contrast, sales of normal balloon catheter in North America will exhibit the lowest CAGR in the market through 2022.

By indication, coronary artery disease will remain dominant in the global market, with sales poised to surpass US$ 1,000 Mn in revenues by 2022-end. Approximately three-fourths revenue share of the market will be accounted for sales of a normal balloon catheter for coronary artery disease from 2017 to 2022.

Hospitals to Remain the Largest End-Users of Normal Balloon Catheter

Sales of normal balloon catheter in cardiac catheterization laboratories are expected to exhibit the fastest expansion through 2022, based on end-users. Hospitals will remain the largest end-users of normal balloon catheter throughout the forecast period.

Nylon will continue to be the preferred raw material for manufacturing normal balloon catheter. Nearly half the revenue share of the market will be accounted for nylon, based on raw material. However, sales of polyurethane for the production of normal balloon catheter will register a comparatively higher CAGR than sales of nylon through 2022.

Competition Tracking

Key players profiled in Fact.MR’s report include

• Abbott Laboratories
• Boston Scientific Corporation
• Medtronic plc
• Terumo Corporation
• MicroPort Scientific Corporation
• B. Braun Melsungen AG
• Meril Life Sciences Pvt. Ltd.
• Hexacath
• Tokai Medical Products Inc.
• Cook Medical INC
• Cordis Corporation
• BIOTRONIK SE & Co. KG.

Market Taxonomy

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

Rising prevalence of patients with end stage renal disease, and growth in interventional cardiology will facilitate the utilization of the normal balloon catheters. Normal balloon catheter manufacturers are focusing on the development of cost-effective and more efficient solutions. This Fact.MR report analyzes the expansion of global normal balloon catheter market till date, and provides key insights on the growth of the market during the forecast period, 2017-2022.

Scope

The scope of Fact.MR’s report is to analyze the global normal balloon catheter market for the forecast period 2017-2022 and provide readers an unbiased and accurate analysis.

Medical device manufacturers, research institutes, and raw material suppliers in the global normal balloon catheter market can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to leading trade magazines and medical journals pertaining to normal balloon catheter.

Summary

The report commences with a brief information of the global normal balloon catheter market. This executive summary sets the tone for the rest of the report, providing users the scope of the report. The executive summary includes important facts and statistics on the global normal balloon catheter market.

Overview

The next section offers an overview of the global normal balloon catheter market. This comprises an introduction to the market, along with a standard definition of the product – normal balloon catheter. In this section, market value and year-over-year growth is offered to the readers. Year-over-year growth provides readers with a broader view of growth patterns over the forecast period.

The report’s succeeding section focuses on drivers, restraints and key trends from macroeconomic, demand, and supply perspectives. Impact analysis of weighted average model-based growth drivers is contained in the report for better provision of decision-making insights to clients.

In order to offer readers with up-to-date information about the latest advancements in the global normal balloon catheter market, the report provides updates about market opportunities, which can benefit leading manufacturers of normal balloon catheter. With continuous evolution of the healthcare sector, keeping a record of latest developments and trends is fundamental for normal balloon catheter manufacturers to formulate key business strategies. Detailed insights about raw material sourcing, supply chain, regulatory approvals, pricing analysis, list of distributors, and cost structure are provided in this section.

Fact.MR’s report on the global normal balloon catheter market offers a comprehensive segmentation forecast and analysis, with an aim to cover the wide scope of the market. A detailed forecast based on countries across all key parameters has been provided in the report. The market has been segmented on the basis of indication, raw material, end-users, and region.

The report’s last section comprises of the global normal balloon catheter market competitive landscape, to provide readers with the dashboard view of company analysis and market players. This competitive intelligence is based on the providers’ categories across value chain, and their presence in the global normal balloon catheter market.

Research Methodology

Fact.MR is committed to offer unbiased and independent market research solutions to its clients. Each market report of Fact.MR is compiled after months of exhaustive research. We bank on a mix of tried-and-tested and innovative research methodologies to offer the most comprehensive and accurate information. Our main sources of research include,

• Primary research
• Secondary research
• Trade research
• Focused interviews
• Social media analysis